Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Regulation of abdominal pain by colitogenic T cells
▸ Boué J, Basso L, Cenac N, et al. Endogenous regulation of visceral pain via production of opioids by colitogenic CD4(+) T cells in mice. Gastroenterology 2014;146:166–75.
Severe abdominal pain represents a major symptom among patients with inflammatory bowel disease (IBD). IBD is largely attributed to a dysregulated response of effector CD4 cells against the microbiota. Accumulation of effector CD4 T cells at the site of a microbe infection leads to increased opioid synthesis to relieve somatic pain; however, whether this opioid production also occurs in the context of intestinal inflammation is unknown. In this study, Boué and colleagues set out to investigate whether colitogenic CD4 T cells that accumulate in the inflamed colon also produce opioids and are able to counteract inflammation-induced visceral pain in mice. Colitis was induced via transfer of naïve CD4 T cells to immune-deficient mice or by administration of dextran sulfate sodium. In the T cell-mediated model, TH1 and TH17 cells accumulating in inflamed intestinal mucosa produced opioids. Opioid mRNA was highly expressed in mucosal T cells but not in naïve CD4 cells before their transfer, suggesting that the ability to produce opioids is acquired upon activation of colitogenic CD4 T cells. Blocking the peripheral opioid receptor increased visceral sensitivity; therefore, stimulation of opioid receptors by endogenous opioids locally released in the inflamed intestine inhibits inflammation-induced visceral pain. The analgesic property of colitogenic T cells was also demonstrated in the mucosal-damage model of acute DSS-induced colitis. This study makes the paradoxical finding that proinflammatory colitogenic CD4 cells promote intestinal inflammation and colonic tissue damage, but concomitantly produce an opioid-mediated analgesic effect that reduces the pain associated with intestinal inflammation. Since severe abdominal pain is a symptom that would warrant an exam by a physician, the analgesic properties of colitogenic T cells may be harmful to …
Competing interests None.
Provenance and peer review Not commissioned; internally peer reviewed.